SCHEMBL240363

SCHEMBL240363

O=C(O)c1ccccc1-c1ccccc1OC(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.49
FABP5 Q01469 1/20 0.49
DHODH Q02127 1/20 0.49
ALDH1A1 P00352 5/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
RORC P51449 2/20 0.48
FFAR4 Q5NUL3 1/20 0.48
SCN10A Q9Y5Y9 1/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
CYP2C9 P11712 3/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX12 P18054 1/20 0.45
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALOX15 P16050 1/20 0.43
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 4/20 0.43
HPGD P15428 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28500487 0.86 PTGER1 (0.59) FABP4FABP5DHODHALDH1A1L3MBTL1
SCHEMBL29374906 0.85 KDM4E (0.53) ALDH1A1RXRARXRBRXRGCYP2C9
SCHEMBL219675 0.85 KDM4E (0.53) ALDH1A1RXRARXRBRXRGCYP2C9
SCHEMBL15391364 0.85 SCN9A (0.50) ALDH1A1L3MBTL1SCN10ACYP2C9CYP3A4
SCHEMBL7123010 0.83 MAPT (0.50) FABP4FABP5ALDH1A1L3MBTL1FFAR4
SCHEMBL1400237 0.82 RORC (0.47) FABP4FABP5DHODHALDH1A1L3MBTL1
SCHEMBL13601645 0.81 FABP4 (0.52) FABP4FABP5DHODHALDH1A1L3MBTL1
SCHEMBL7701143 0.81 ALDH1A1 (0.50) ALDH1A1L3MBTL1FFAR4SCN10APOLB
SCHEMBL9588403 0.79 HTT (0.62) ALDH1A1SCN10ARXRARXRBRXRG
SCHEMBL14089991 0.79 RXRA (0.54) FABP4FABP5DHODHALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004244-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed
CN-1708491-A N-benzodioxolyl, N-benzodioxanyl and N-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them MERCK PATENT GMBH (DE) 2005-12-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004244-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R FABP4 1626/4885FABP5 3012/4885DHODH 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.